Let the industry know about your research - join our community as a guest writer!
Astraveus

Astraveus

Astraveus has developed an innovative microfluidic bioprocessing unit for the automated production of cell and gene therapies.

 

Contact person: Andrew Shailer-Smith

Job title: CEO
Singularity Sciences Inc.

Singularity Sciences Inc.

At Singularity Sciences we are developing a revolutionary lab-on-a-chip technology for panel-based, low-cost, on-site diagnostics. Our device will be fully patient operated, only require several drops of blood and provide clinically accurate results in minutes. We are a young and talented group of scientists, technologists, and engineers who are determined to modernize direct-to-consumer lab testing and put the power in the patient’s hands.

 

Looking for: Mentors, Investors, Engineers

 

Contact person: Isaac Lichtenstein

Job title: Co-Founder and Chief Medical Officer
Dropletex

Dropletex

Dropletex specializes in manufacturing microfluidic droplet generators for applications in molecular biology, microparticle synthesis, and microorganism studies. The company manufactures easy to use chips that are capable of generating a wide range of droplet size with high monodispersity.

 

Spectradyne

Spectradyne

Spectradyne develops cutting-edge analytical technology that is accelerating drug development in the pharmaceutical industry.

Syntr Health Technologies, Inc

Syntr Health Technologies, Inc

Looking for: Mentors, Investors

 

Contact person: Ahmed Zobi

Job title: CEO
LiveFocus LLC

LiveFocus LLC

LiveFocus is an Ohio based startup working on liquid lenses and the applications.

 

Looking for: Investors, Strategic partners for manufacturing

CelltOmics, LLC

CelltOmics, LLC

Pathology cell processing start-up designed to address the problem of diminutive specimens and the ever-increasing amount of tests being required of them.

 

Looking for: Mentors, Investors

 

Contact person: Wilfrido (Fred) Mojica

Engender Technologies

Engender Technologies

Engender Technologies Limited is a New Zealand company that has developed a technology to separate X- and Y-bearing bull sperm cells. This technology is expected to be low cost and cause minimal discernible damage to the cells. Sex sorting is expected to sustainably accelerate genetic gain and improve cost efficiencies in large animal reproduction.

 

Looking for: Investors

 

Contact person: Kieran Jina

Job title: Operations Manager
BEOnChip

BEOnChip

BEOnChip S.L. is responsible for designing new devices for cell culture, to try to make the environment of the cells is as biomimetic possible. We try that cells in the laboratory behave in exactly the same way as if they were in the human body. like this drug testing will be much closer to the real and therefore the time and cost of manufacturing new drugs to treat diseases like cancer or heart attacks will decrease.

 

Contact person: Alberto Doblaré

Orbis Diagnostics

Orbis Diagnostics

Orbis Diagnostics is developing in-line milking measurement for protein, fat, somatic cell and progesterone. Dairy farmers need to determine ratios and concentration of milk solids (protein and fat) for which they are paid, detect early signs of bovine mastitis through somatic cell counts; and improve reproduction through progesterone monitoring. Orbis’ microfluidic technology is expected to measure more parameters, be more accurate and timely than existing practice, providing the farmer with actionable insight for each cow in their milking herd.

 

Looking for: Investors

 

Contact person: Kieran Jina

Job title: Operations Manager